CVKD (STOCKS)
Cadrenal Therapeutics, Inc. Common Stock
$4.990000
+0.230000 (+4.83%)
Prev close: $4.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Quang X. Pham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12.53M
- Employees
- 4
- P/E (TTM)
- -0.75
- P/B (TTM)
- 4.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $223.82K |
| Operating Expenses | $13.46M |
| Research and Development | $4.10M |
| Other Operating Expenses | $9.36M |
| Operating Income/Loss | -$13.46M |
| Income/Loss From Continuing Operations After Tax | -$13.24M |
| Income/Loss From Continuing Operations Before Tax | -$13.24M |
| Net Income/Loss | -$13.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.24M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.64 |
| Diluted Earnings Per Share | -$6.64 |
| Basic Average Shares | 1,993,757 |
| Diluted Average Shares | 1,993,757 |
| Assets | $4.33M |
| Current Assets | $4.32M |
| Noncurrent Assets | $7.34K |
| Fixed Assets | $5.17K |
| Other Non-current Assets | $2.17K |
| Liabilities | $1.59M |
| Current Liabilities | $1.59M |
| Accounts Payable | $650.66K |
| Other Current Liabilities | $937.32K |
| Noncurrent Liabilities | $0.00 |
| Equity | $2.74M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.74M |
| Liabilities And Equity | $4.33M |
| Net Cash Flow From Operating Activities | -$12.60M |
| Net Cash Flow From Operating Activities, Continuing | -$12.60M |
| Net Cash Flow From Investing Activities | -$5.10K |
| Net Cash Flow From Investing Activities, Continuing | -$5.10K |
| Net Cash Flow From Financing Activities | $6.60M |
| Net Cash Flow From Financing Activities, Continuing | $6.60M |
| Net Cash Flow | -$6.01M |
| Net Cash Flow, Continuing | -$6.01M |
| Comprehensive Income/Loss | -$13.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.24M |
| Other Comprehensive Income/Loss | $0.00 |